| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/16/1998 | EP0883344A1 Therapeutic molecules generated by trans-splicing |
| 12/16/1998 | EP0883343A1 Method for treating ischemic tissue |
| 12/16/1998 | EP0854726B1 Stable extract of hypericum perforatum l., process for preparing the same and pharmaceutical compositions |
| 12/16/1998 | EP0808156B1 Compositions comprising nanoparticles of nsaid |
| 12/16/1998 | EP0762878B1 Use of a naphthalenesulfonic acid compound for inhibiting retroviral infection |
| 12/16/1998 | EP0724572B1 Fused tricyclic heteroaromatic derivatives as dopamine receptor subtype ligands |
| 12/16/1998 | EP0703902B1 Process for the production of piperidine derivatives |
| 12/16/1998 | EP0699191B1 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 12/16/1998 | EP0696585B1 Novel bisoxadiazolidine derivative |
| 12/16/1998 | EP0690842B1 4-arylisoindole analgesics |
| 12/16/1998 | EP0687253B1 4-aminopyridines, process for preparing the same and medicaments containing the same |
| 12/16/1998 | EP0673545B1 Process and apparatus for etching semiconductor wafers |
| 12/16/1998 | EP0672686B1 Ganglioside gm3 derivative having fluorinated ceramide moiety |
| 12/16/1998 | EP0671942B1 Pharmaceutical preparation comprising a beta-lactam antibiotic degrading compound, and use thereof |
| 12/16/1998 | EP0670714B1 Retinoic acid-containing compositions |
| 12/16/1998 | EP0610447B1 CDw52 - SPECIFIC ANTIBODY FOR TREATMENT OF T-CELL MEDIATED INFLAMMATION OF THE JOINTS |
| 12/16/1998 | EP0592453B1 Aminoalkyl-substituted 2-amino-1,3,4-thiadiazoles, their preparation and their use |
| 12/16/1998 | EP0576506B1 Use of benzimidazole anthelmintic in the treatment of microsporidial infections |
| 12/16/1998 | EP0532752B1 Compound tan-1251, its derivatives, their production and use |
| 12/16/1998 | EP0454781B1 Recombinant cells for therapies of infection and hyperproliferative disorders and preparation thereof |
| 12/16/1998 | CN1202200A Fas ligang fusion protein |
| 12/16/1998 | CN1202173A Amine derivatives of epipodophyllotoxin 2',3'-dideoxyglycosides, preparation method therefor and use thereof as drug and for treating cancer |
| 12/16/1998 | CN1202170A Quinoline derivatives as type 1V phosphodiesterase inhibitors |
| 12/16/1998 | CN1202169A 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3H)-one derivatives for use as 5-HT4 or H3 receptor ligands |
| 12/16/1998 | CN1202168A Quinolein-2(1H)-one derivatives as serotonin antagonists |
| 12/16/1998 | CN1202166A Hydrolysis-promoting taxane hydrophobic derivatives |
| 12/16/1998 | CN1202164A Diarylalkenylamine derivatives |
| 12/16/1998 | CN1202163A Benzothiazolone derivatives |
| 12/16/1998 | CN1202161A Macrocyclic compounds as metalloprotease inhibitors |
| 12/16/1998 | CN1202160A Compounds potentiating retinoid |
| 12/16/1998 | CN1202156A Cyclic and heterocyclic n-substituted 'alpha'-iminohydroxamic acid carboxylic acids |
| 12/16/1998 | CN1202155A Antimalarial quinolin derivatives |
| 12/16/1998 | CN1202154A Aromatic carboxylic acid esters, production of same and use of same as medicaments |
| 12/16/1998 | CN1202153A 3-(4-subst.-piperidinyl-1)-1-(3,4-dichlorophenyl) propyl carbamates and ureas and derivatives as neurokinin antagonists |
| 12/16/1998 | CN1202152A 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency |
| 12/16/1998 | CN1202151A Sulfur containing di-tert-butylphenol compounds useful as anti-inflammatory agents |
| 12/16/1998 | CN1202114A Aqueous prolonged release formulation |
| 12/16/1998 | CN1202113A Pharmaceutical combination preparations containing erythropoietin and iron preparation |
| 12/16/1998 | CN1202111A Use of epinastine in the treatment of pain |
| 12/16/1998 | CN1202110A Antibacterial composition for oral administration |
| 12/16/1998 | CN1202109A Kainic acid neuronotoxicity inhibitors and pyridothioazine derivatives |
| 12/16/1998 | CN1202108A Carbostyril derivatives for curing ophthalmological diseases |
| 12/16/1998 | CN1202107A Selective 'beta'3 adrenergic agonists |
| 12/16/1998 | CN1202106A Selective 'beta'3 adrenergic agonists |
| 12/16/1998 | CN1202105A 2-alkylpyrrolidines |
| 12/16/1998 | CN1202104A Methods and compositions for stimulating neurite growth |
| 12/16/1998 | CN1202103A Excitatory amino acid receptor antagonists |
| 12/16/1998 | CN1201791A Antiallergic agent having anti-oxidant action |
| 12/16/1998 | CN1201789A Pyridine-3,4-diketone derivatives and their preparation and medicinal uses |
| 12/16/1998 | CN1201685A Ginkgo and calcium capsule |
| 12/16/1998 | CN1201680A Pill for pelvic inflammation and cervical erosion |
| 12/16/1998 | CN1201667A Infusion for burn and scald |
| 12/16/1998 | CN1201665A Slowly releasing implanted medicines of penicillins and preparation thereof |
| 12/16/1998 | CN1041204C Pentacyclic triterpenoid compound as toposomerase inhibitors or cell differentiation inducers |
| 12/16/1998 | CN1041203C Preparation of pyrazolopyridine compound |
| 12/16/1998 | CN1041202C Quinolone carboxylic acid derivative |
| 12/16/1998 | CN1041201C Vitamin D3-analogies, their preparation, their medical compositions and usages |
| 12/16/1998 | CN1041169C Quick-acting enterogastritis medicine and preparing process thereof |
| 12/16/1998 | CN1041166C Use of complexes and chelates resp., of antibiotics with bivalent and/or trivalent metals in obtaining of antiulcer, complexes and chelates |
| 12/15/1998 | US5849991 Mice homozygous for an inactivated α 1,3-galactosyl transferase gene |
| 12/15/1998 | US5849943 Stilbene derivatives useful as cyclooxygenase-2 inhibitors |
| 12/15/1998 | US5849930 Pyrazolidine derivative radical scavenger brain-infarction depressant and brain-edema depressant |
| 12/15/1998 | US5849924 Highly selective process for the preparation of enantiomerically pure phenyl-substituted 1,4-dihydropyridine-3,5-dicarboxylic acid derivatives |
| 12/15/1998 | US5849923 Heterocyclic-substituted naphthalenyl retinobenzoic acid derivatives |
| 12/15/1998 | US5849919 Fused benzeneoxyacetic acid derivatives which have PGI2 receptor anonist activity |
| 12/15/1998 | US5849918 Amino acid derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds |
| 12/15/1998 | US5849915 Buprenorphine analgesic analogues |
| 12/15/1998 | US5849912 Biphenyl derivatives |
| 12/15/1998 | US5849903 Antisense oligonucleotides for IL-8 and IL-8 receptor |
| 12/15/1998 | US5849902 Three component chimeric antisense oligonucleotides |
| 12/15/1998 | US5849893 Nucleic acid-binding oligomers possessing C-branching for therapy and diagnostics |
| 12/15/1998 | US5849889 Oligosaccharide-containing 14 aminosteroid compounds and novel diastereoselective aminosteroid process chemistry |
| 12/15/1998 | US5849860 Polyethylene-protein conjugates |
| 12/15/1998 | US5849803 Method of treating erectile dysfunction with nitroglycerine |
| 12/15/1998 | US5849800 Use of amantadine for treatment of Hepatitis C |
| 12/15/1998 | US5849799 Use of deoxyspergualin for preparing a pharmaceutical for treating hyperreactive inflammatory diseases |
| 12/15/1998 | US5849798 Polyaromatic heterocyclic compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 12/15/1998 | US5849797 D-β-lysylmethanediamine derivatives and preparation thereof |
| 12/15/1998 | US5849796 Ortho-substituted benzoil acid derivatives |
| 12/15/1998 | US5849794 Guanylhydrazones and their use to treat inflammatory conditions |
| 12/15/1998 | US5849793 HIV matrix protein tyrosine position 29 pocket binders |
| 12/15/1998 | US5849792 Storage-stable prostaglandin compositions |
| 12/15/1998 | US5849791 Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
| 12/15/1998 | US5849789 Use of 4-amino-4-(4-fluorobenzylamino)-1-ethoxy-carbonylaminobenzene for the prophylaxis and treatment of reduced cerebral blood supply |
| 12/15/1998 | US5849788 Compound for treatment of cardiac arphythmia, synthesis, and methods of use |
| 12/15/1998 | US5849787 Hypercholesterolemia therapeutic agent |
| 12/15/1998 | US5849786 Process for the treatment or prevention of herpes |
| 12/15/1998 | US5849784 Cyclic sulfone containing retroviral protease inhibitors |
| 12/15/1998 | US5849783 Autobiotics and their use in eliminating nonself cells |
| 12/15/1998 | US5849782 Methods of inhibiting neurodegenerative diseases |
| 12/15/1998 | US5849781 Tricyclic amides |
| 12/15/1998 | US5849779 Pyrazole derivatives and their pharmaceutical use |
| 12/15/1998 | US5849777 Cell differentiation induction with mevalonate and mevalonolactone derivatives |
| 12/15/1998 | US5849776 Medicaments based on metronidazole or on a synergic mixture of metronidazole and clindamycin |
| 12/15/1998 | US5849775 Substituted benzoylguanidines process for their preparation, their use as a medicament or diagnostic, and pharmaceutical containing them |
| 12/15/1998 | US5849774 Treatment of sepsis-induced acute renal failure |
| 12/15/1998 | US5849773 Amino acyl amino propargyl diol compounds for treatment of hypertension |
| 12/15/1998 | US5849772 Carbamate compounds and processes for preparing the same |
| 12/15/1998 | US5849771 Phosphorylated nitrone derivatives, method for preparing same, and compositions containing said derivatives |
| 12/15/1998 | US5849770 Tri-substituted phenyl derivatives useful as PDE IV inhibitors |